Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 20;13:990594. doi: 10.3389/fgene.2022.990594

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Lu, Liu, Wang, Zhang and Li.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Analysis of immunotherapy and chemotherapy responses based on m5C-related lncRNAs risk model. (A) Comparison of TIDE scores between the high-risk and low-risk groups. (B) The difference of 34 immune checkpoints expression level between high- and low-risk groups shown in the box plot. (C) Differences in PD-L1 expression between high- and low-risk groups. IC₅₀ of axitinib (D), dasatinib (E), doxorubicin (F), erlotinib (G), gemcitabine (H), mitomycin.C (I), rapamycin (J), and sorafenib (K) in high- and low-risk groups.